|
ENTA Enanta Pharmaceuticals Inc 1177648 |
| Balance Sheet |
|
Current Assets
|
268,145,000 |
|
Assets
|
348,642,000 |
|
Current Liabilities
|
49,050,000 |
|
Liabilities
|
236,826,000 |
|
Equity
|
111,816,000 |
|
Shares Out
|
21,189,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-16,801,000 |
|
Investing Cash Flow
|
68,903,000 |
| Market Analysis |
Market Cap
|
249,813,121 |
|
Price
|
6.43 |
|
BVPS
|
5.28 |
|
PB
|
1.18 |
|
EPS
|
-5.46 |
|
PS
|
3.68 |
|
FCF
|
52,102,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ENTA documents filed with the SEC.
ENTA Filings
Clear
